EAS Newsletter February 21, 2023

EAS Education

EAS Rare Lipid Disorder Courses 2023

While the prevalence of each individual Rare Lipid Disorder is low, collectively they are important and the busy specialized practitioner will encounter patients with these conditions. Lipidologists need to be familiar with their diagnosis and treatment as they may be associated with high morbidity and mortality. EAS run Rare Lipid Disorder Courses to improve recognition and understanding in this. The courses’ objectives are to review practical aspects of evaluation and management, and to describe real clinical cases of these disorders.

The programme of Rare Lipid Disorder courses held during 2023 is now available on the website.

Do not miss the Advancd course in Rare Lipid DIsorders from Spain/Portugal, held Friday April 14, 16:00 CET.
Endorsed by Sociedade Portuguesa de Aterosclerose & Sociedad Española de Arteriosclerosis
Course directors: Prof Pedro Valdivielso and Dr Sequeira Duarte 
Location/Format: Virtual
Language: English

EAS Education: 

Webinar- all you need to know about the CLEAR OUTCOMES trial results

It is our pleasure to invite you to a webinar organised by EAS for the Society’s clinical community, including the Lipid Clinic Network members and Society members.
The Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial will be discussed at ACC.23.
In this webinar, open to EAS scientific and medical community, EAS experts look into what these new results may mean in clinical practice.
Join this EAS webinar to gain understanding of the scientific basis for the study & the role of bempedoic acid in lipid-lowering therapy and CVD management.
We will be discussing key messages from the trial results, and exploring the implications of the trial findings on clinical practice.

Join us on Monday March 13, 2023
Start time: 19:00 CET
Registration is free

Webinar Programme

  1. Introduction & welcome, by Chair, Lale Tokgozoglu, Turkey
  2. Study design, speaker Maciej Banach, Poland
  3. CLEAR Outcomes trial – results & key findings, speaker Steve Nicholls, Australia
  4. How will this change my clinical practice?, speaker Ulrich Laufs, Germany
  5. Panel Discussion: Maciej Banach, Ulrich Laufs, Steve Nicholls, Lale Tokgozoglu & Alberico L. Catapano
  6. Wrap up, summary, by Chair Alberico L. Catapano, Italy

EAS have independently created and organised the programme for this webinar. Financial support has been provided by Daiichi-Sankyo.

EAS Society & Governance: EAS Executive Committee elections 2023

Last call for nominations! Deadline March 01

Last chance to be an active member and nominate your candidates to the EAS Executive Committee, the elected governing body responsible for the running of the Society. Its members determine the scientific direction of the Society, and are responsible for strategic planning of EAS activities. Nominate your candidates for the following positions:

  • President-Elect (2024-2028)
  • Executive Committee member (2024-2027)

Deadline to nominate is March 1!

Please note you have to be an EAS Individual Member to be able to nominate a candidate for a vacant position at the EAS Executive committee. 
Read here on how to become an EAS Individual Member >>

EAS Congress:

Register to EAS Congress in Mannheim, Germany

Join us May 21-24 in Mannheim, Germany to network with your colleagues from around the world, explore the latest science and innovation in atherosclerosis research and clinical practice, lectures by world leading experts, up-and-coming students, and everyone in between.
EAS Congress brings together delegates with wide-ranging interests, making for lively discussion and innovative approaches, as we tackle mutual challenges each from our own perspective. 

The Congress features:

  • Plenary sessions with lectures given by eminent speakers
  • In-depth Workshops on selected cutting-edge topics
  • Industry-supported symposia
  • Science-at-a-Glance and poster presentations
  • …and much more! Register today!